582023b7-figure-01 (Image 1)
Hydrochlorothiazide
Product Images NDC 53002-1702
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 53002-1702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label Image (Lbl530021702)
Hydrochlorothiazide 12.5 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a supply of 30 tablets with directions to take one tablet daily or as directed. It includes space for patient and prescriber information, dosage instructions, and billing codes. The label highlights the drug's strength, dosage form, and prescription-only status.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
